Alpha-Maven Cannabis Investment Dashboard:

Top Cannabis Investment News, Member Posts, Cannabis Investment Daily Indices and more!

1mo ago Cannabis harrisbricken Views: 210

Second verse, same as the first, a whole lot louder and a lot MORE woke. The House of Representatives passed the first version of the MORE Act at the end of 2020. The bill promptly died in the Republican-controlled Senate. This blog tracked the evolution of the bill’s original version: demystifyingthe bill, dispellingsome myths and misunderstandings about federal legalization, and predictingthe bill’s demise. The Housereintroducedthe second version of the bill on May 28th, 2021. This version is the same as the first with the addition of some progressive upgrades.Most notably, drafters of the billremoved languagethat barred applicants with felony cannabis convictions from federal permitting. This language proved controversial at the time of the passage of the 2020 MORE Act. Denying federal permitting to those directly impacted by prohibition seemed counterintuitive to the stated intention of the bill,“to provide for reinvestment in certain persons adversely impacted by the War on Drugs.” Removing this language shows that Congress aims for an even more progressive vision of legalization this time around. Notably, the MORE Act 2021 has received resounding support from Amazon. The company offered its formal supportfor not only the new MORE Act, but for cannabis legalization in general. Amazon’s representative even promised that it would change its drug testing policy for some employees to allow for cannabis use. Amazon’s support for the MORE Act speaks volumes and suggests that the company may see profit-making potential in federal legalization. What’s more, the corporation’s size and ubiquity could compel other companies, Congress, and the President, to broaden support for federal legalization. So, you might be wondering if there is hope for this new bill. Unfortunately, even with a Democratic majority in both houses, a Democratic President, and support from Amazon, the short answer is still no, not really. The bill needs 60 votes to pass the Senate. That’s a vote from every Democrat plus ten Republicans. The progressive language of the new bill takes an important step towards addressing the harms of the Drug War. But progressivism probably won’t appeal to the reluctant centrist Democrats and the ten Republicans needed to pass the bill in the Senate. As it stands, conservative legalization bills have a better chance of passing, bills such as the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act (an unfortunate name with far less pun-tential than MORE). Barring some political miracle (such asending thefilibuster), the MORE Act most likely won’t make it to President Biden’s desk. We will keep you posted. Federal Legalization: The New MORE Act on Harris Bricken. -

Today's Cannabis Investment Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.